Production (Stage)
Cellectis S.A.
CMVLF
$1.25
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.66M | 12.72M | 16.20M | 8.06M | 4.53M |
| Total Other Revenue | 1.37M | 2.45M | 1.85M | 1.44M | 1.97M |
| Total Revenue | 12.03M | 15.17M | 18.05M | 9.50M | 6.50M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 12.03M | 15.17M | 18.05M | 9.50M | 6.50M |
| SG&A Expenses | 4.70M | 4.93M | 5.17M | 3.88M | 5.10M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -426.00K | 47.00K | -175.00K | -686.00K | -35.00K |
| Total Operating Expenses | 26.21M | 25.85M | 28.82M | 26.71M | 27.39M |
| Operating Income | -14.18M | -10.68M | -10.77M | -17.21M | -20.90M |
| Income Before Tax | -18.13M | 6.44M | -23.12M | -25.46M | 5.38M |
| Income Tax Expenses | -- | 514.00K | -59.00K | -193.00K | -262.00K |
| Earnings from Continuing Operations | -18.13M | 5.92M | -23.06M | -25.27M | 5.64M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.13M | 5.92M | -23.06M | -25.27M | 5.64M |
| EBIT | -14.18M | -10.68M | -10.77M | -17.21M | -20.90M |
| EBITDA | -11.13M | -7.45M | -8.00M | -14.47M | -18.33M |
| EPS Basic | -0.18 | 0.06 | -0.23 | -0.28 | 0.08 |
| Normalized Basic EPS | -0.11 | 0.03 | -0.12 | -0.18 | 0.05 |
| EPS Diluted | -0.18 | 0.06 | -0.23 | -0.28 | -0.15 |
| Normalized Diluted EPS | -0.11 | 0.03 | -0.12 | -0.18 | 0.03 |
| Average Basic Shares Outstanding | 100.16M | 100.09M | 100.09M | 89.85M | 71.81M |
| Average Diluted Shares Outstanding | 100.16M | 100.09M | 100.09M | 89.85M | 103.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |